ARTÍCULOS-casos

NOTA: En esta sección se recogen artículos elaborados por autores españoles o pertenecientes a instituciones españolas.

General

  1. García Espinosa J, et al. COVID-19 grave con inicio como neumonía bilateral, ictus isquémico e infarto de miocardio. Med Clin (Barc). 2020 Aug 28;155(4):188 [doi
  2. Carriel J, et al. CURB-65 como predictor de mortalidad a 30 días en pacientes hospitalizados con COVID-19 en Ecuador: Estudio COVID-EC. Rev Clin Esp. 2020 Oct 22 [doi
  3. Hoefer A, et al. Management of a COVID-19 outbreak in a hotel in Tenerife, Spain. Int J Infect Dis. 2020 Jul;96:384-386 [doi
  4. Cucchiari D, et al. Pneumococcal superinfection in COVID-19 patients: A series of 5 cases. Med Clin (Barc). 2020 Dec 11;155(11):502-505 [doi
  5. Alcántara Montero A, et al. Posibles factores protectores de la infección por SARS-CoV-2 en una paciente vulnerable: a propósito de un caso. Semergen. 2020 Aug;46 Suppl 1:95-98 [doi
  6. Hodcroft EB. Preliminary case report on the SARS-CoV-2 cluster in the UK, France, and Spain. Swiss Med Wkly. 2020;150(9-10):10.4414/smw.2020.20212 [doi]
  7. Crespo Sabarís R, et al. SARS-CoV-2: una presentación peculiar. Semergen. 2020 Aug;46 Suppl 1:99-100 [doi

Anatomía Patológica

  1. Navarro Conde P, et al. Autopsy findings from the first known death from Severe Acute Respiratory Syndrome SARS-CoV-2 in Spain. Rev Esp Patol. 2020;53(3):188-192 [doi
  2. Comino-Trinidad O, et al. Disseminated intravascular coagulation as a form of presentation of coronavirus-19 disease. Clinical case. Rev Esp Anestesiol Reanim. 2021 Jan;68(1):41-45 [doi

Anestesiología

  1. González AM, et al. Analysis of the care management protocol for COVID pregnant women and detection of improvement proposals applying clinical simulation methodology. Rev Esp Anestesiol Reanim. 2020 Nov;67(9):487-495 [doi]
  2. Martínez Santos L, et al. Anesthetic planning and management for a caesarian section in a pregnant woman affected by SARS-COV-2 pneumonía. Rev Esp Anestesiol Reanim. 2021 Jan;68(1):46-49 [doi
  3. Simón Polo E, et al. Bilateral psoas muscle hematoma in critical patient COVID-19. Cir Esp (Engl Ed). 2021 Feb 27:S0009-739X(21)00073-7 [doi
  4. González-Castro A, et al. High-flow oxygen therapy with spontaneous breathing prono position in SARS-CoV-2 pneumonia. Rev Esp Anestesiol Reanim. 2020 Nov;67(9):529-530 [doi
  5. Del Castillo Pardo de Vera JL, et al. Hybrid tracheotomy. A valid alternative for obese critical patients COVID-19. Rev Esp Anestesiol Reanim. 2020 Oct;67(8):483-484 [doi
  6. Garví López M, et al. Intracranial hemorrhages in critical COVID-19 patients: report of three cases. Med Clin (Barc). 2021 Jan 8;156(1):38-39 [doi
  7. Azpiazu Landa N, et al. Ischemic-hemorrhagic stroke in patients with Covid-19. Rev Esp Anestesiol Reanim. 2020 Nov;67(9):516-520 [doi
  8. Amador Penco FB, et al. Massive subcutaneous emphysema in patient SARS-CoV-2 positive. Rev Esp Anestesiol Reanim. 2020 Nov;67(9):532-533 [doi
  9. López Pérez V, et al. Postpartum consciousness disturbance: can covid-19 cause posterior reversible encephalopathy syndrome? Rev Esp Anestesiol Reanim. 2020 Nov;67(9):511-515 [doi

Angiología

  1. Salvat Dávila C, et al. Hallazgo casual en estudio PET/TC con 18F-FDG para el diagnóstico de vasculitisRev Esp Med Nucl Imagen Mol. 2020 Jul 10;S2253-654X(20)30117-7 [doi]

Aparato Digestivo

  1. Gonzalo-Voltas A, et al. Acute pancreatitis in a patient with COVID-19 infection. Med Clin (Barc). 2020 Aug 28;155(4):183-184 [doi
  2. Rodríguez-Lago I, et al. Characteristics and prognosis of patients with inflammatory bowel disease during the SARS-CoV-2 pandemic in the Basque Country (Spain). Gastroenterology. 2020 Apr 21;S0016-5085(20)30560-6 [doi]
  3. Marín-Jiménez I, et al. COVID-19 y enfermedad inflamatoria intestinal: preguntas surgidas de la atención y seguimiento de los pacientes durante la fase inicial de la pandemia (febrero-abril 2020). Gastroenterol Hepatol. 2020 May 15;10.1016/j.gastrohep.2020.05.003 [doi
  4. Brunet E, et al. Ileitis as the exclusive manifestation of COVID-19. The first reported case. Gastroenterol Hepatol. 2020 Oct 19:S0210-5705(20)30372-1 [doi
  5. Saura N, et al. Liver injury associated with SARS-CoV-2: a case report. Gastroenterol Hepatol. 2021 Jun 19:S0210-5705(21)00200-4 [doi
  6. Martin Arranz E, et al. Management of COVID-19 Pandemic in Spanish Inflammatory Bowel Disease Units: Results From a National Survey. Inflamm Bowel Dis. 2020;izaa142 [doi]
  7. Gonzalo-Voltas A, et al. Pancreatitis aguda en paciente con infección por COVID-19. Med Clin (Barc). 2020 Jun 9;S0025-7753(20)30354-7 [doi

Atención primaria

  1. Aguilar-Shea AL, et al. Cambio de color de pie tras COVID-19. Semergen. 2021 Apr 20:S1138-3593(21)00087-3 [doi
  2. Peiró Morant JF, et al. Disnea como síntoma de alarma. Importancia de la atención primaria en un nuevo modelo de atención a pacientes COVID-19. Semergen. 2021 Jan-Feb;47(1):59-61
  3. Zafra-Sánchez JJ, et al. No es COVID-19 todo lo que reluce. Semergen. 2020 Oct;46(7):503-504 [doi
  4. Alcántara Montero A, et al. Posibles factores protectores de la infección por SARS-CoV-2 en una paciente vulnerable: a propósito de un caso. Semergen. 2020 Jun 5;S1138-3593(20)30191-X [doi
  5. Piera Carbonell A, et al. Trombosis y COVID-19: Atención Primaria clave en el abordaje interdisciplinar. Semergen. 2020 Aug;46 Suppl 1:93-94 [doi

Cardiología

  1. Cárdenes León A, et al. Acute coronary syndrome and shock in the context of acute COVID-19 infection. Rev Esp Cardiol (Engl Ed). 2020 Aug;73(8):678-679 [doi]
  2. Tung-Chen Y. Acute pericarditis due to COVID-19 infection: An underdiagnosed disease? Med Clin (Barc). 2020 May 4;S0025-7753(20)30257-8 [doi]
  3. Rudilosso S, et al. Acute Stroke Care Is at Risk in the Era of COVID-19: Experience at a Comprehensive Stroke Center in Barcelona. Stroke. 2020 May 22;STROKEAHA120030329 [doi]
  4. Álvarez-Rodríguez E, et al. Aprendiendo con el COVID-19: ¿qué pasa con la anticoagulación?
    . An Sist Sanit Navar. 2020 Aug 31;43(2):251-254 [doi
  5. Rey JR, et al. Arterial thrombotic complications in hospitalized patients with COVID-19. Rev Esp Cardiol (Engl Ed). 2020 Sep;73(9):769-771 [doi]
  6. López-Otero D, et al. Asociación entre el daño miocárdico y el pronóstico de pacientes hospitalizados por COVID-19, con y sin cardiopatía. Registro CARDIOVID. Rev Esp Cardiol. 2021 Jan;74(1):105-108 [doi
  7. Caballeros Lam M, et al. Cardiac magnetic resonance characterization of COVID-19 myocarditis. Rev Esp Cardiol (Engl Ed). 2020 Oct;73(10):863-864 [doi]
  8. Rey JR, et al. Complicaciones arteriales trombóticas en pacientes hospitalizados con COVID-19. Rev Esp Cardiol. 2020 Sep;73(9):769-771 [doi
  9. Rey JR, et al. Complicaciones arteriales trombóticas en pacientes hospitalizados con COVID-19. Respuesta a cartas relacionadas. Rev Esp Cardiol. 2021 Jan;74(1):116 [doi
  10. Torres González N, et al. Control electrocardiográfico del intervalo QT mediante dispositivo portátil en pacientes ingresados por COVID-19. Propuesta de protocolo. Rev Esp Cardiol. 2020 Sep;73(9):771-773 [doi
  11. Sánchez-Recalde Á, et al. COVID-19 and cardiogenic shock. Different cardiovascular presentations with high mortality. Rev Esp Cardiol (Engl Ed). 2020;73(8):669-672 [doi]
  12. Bernal-Torres W, et al. COVID-19 fulminant myocarditis: a case report. Eur Heart J Case Rep. 2020 Jul 8;4(FI1):1-6 [doi
  13. Sánchez-Recalde Á, et al. COVID-19 y shock cardiogénico: diferentes formas de presentación cardiovascular con alta mortalidad. Rev Esp Cardiol. 2020 Apr 30;10.1016/j.recesp.2020.04.018 [doi]
  14. Rey JR, et al. COVID-19 y trombosis simultánea en dos arterias coronarias. Rev Esp Cardiol. 2020 May 13;10.1016/j.recesp.2020.05.004 [doi]
  15. Nuche J, et al. Curso clínico de la COVID-19 en pacientes con hipertensión arterial pulmonar. Rev Esp Cardiol. 2020 Sep;73(9):775-778 [doi
  16. Aldama G, et al. Descenso del número de angioplastias primarias durante la pandemia y su relación con la mortalidad por COVID-19. El papel de los riesgos competitivos. Rev Esp Cardiol. 2021 May;74(5):474-476 [doi]
  17. Gonzalez-Fernandez O, et al. Dímero D y alteraciones del ventrículo derecho como factores pronósticos en pacientes críticos con COVID-19. Rev Esp Cardiol. 2020 Nov;73(11):966-968 [doi
  18. Tung-Chen Y, et al. Dolor torácico persistente tras resolución de la enfermedad por coronavirus 2019 (COVID-19). Semergen. 2020 Jun 11;S1138-3593(20)30198-2 [doi
  19. Vannini L,et al. Embolia pulmonar aguda durante la cuarentena por COVID-19. Rev Esp Cardiol. 2020 Aug;73(8):680-682 [doi
  20. Climent FJ, et al. Evolución mortal de la enfermedad COVID-19 en un lactante de 5 meses con comorbilidad. Rev Esp Cardiol (Engl Ed). 2020;73(8):667-669 [doi]
  21. Pla JJ, et al. Free-floating right heart thrombus with pulmonary embolism in SARS-CoV-2 patient. Med Clin (Barc). 2020 Nov 13;155(9):415-416 [doi
  22. Irabien-Ortiz Á, et al. Fulminant myocarditis and COVID-19. Response. Rev Esp Cardiol (Engl Ed). 2020 Oct;73(10):865-866 [doi
  23. Lozano Gómez H, et al. Fulminant myocarditis and cardiogenic shock during SARS-CoV-2 infection. Med Clin (Barc). 2020 Nov 27;155(10):463-464 [doi
  24. Rodríguez-Santamarta M, et al. Hallazgos ecocardiográficos en pacientes críticos por COVID-19. Rev Esp Cardiol. 2020 Oct;73(10):861-863 [doi
  25. Carrión-Sánchez I, et al. Hospital admissions due to coronary events during SARS-CoV2 pandemic. Med Clin (Barc). 2021 Feb 26;156(4):191-192 [doi
  26. Salgado Aranda R, et al. Impacto de la primera ola de la pandemia de SARS-CoV-2 en la tasa de implante de marcapasos con indicación preferente/urgente. Estudio español. Rev Esp Cardiol. 2021 May;74(5):469-472 [doi
  27. Cantador E, et al. Incidence and consequences of systemic arterial thrombotic events in COVID-19 patients. J Thromb Thrombolysis. 2020 Oct;50(3):543-547 [doi
  28. Marsico S, et al. Infarto pulmonar secundario a tromboembolia pulmonar en COVID-19 diagnosticada con angiotomografía computarizada pulmonar con energía dual. Rev Esp Cardiol. 2020 Aug;73(8):672-674 [doi
  29. Pons-Pellicé L, et al. Middle cerebral artery stroke due to paradoxical embolism in a patient with COVID-19 pneumonia. Rev Esp Cardiol (Engl Ed). 2021 Feb 5:S1885-5857(21)00047-5 [doi
  30. Irabien Ortiz A. Miocarditis fulminante por COVID-19. Rev Esp Cardiol. 2020;73(6):503-504 [doi
  31. Irabien-Ortiz Á, et al. Miocarditis fulminante por COVID-19. Respuesta. Rev Esp Cardiol. 2020 Jun 19;S1885-5857(20)30269-3 [doi
  32. Cuevas Vilaplana A, et al. Miocarditis y trombosis in situ en ventrículo derecho en paciente COVID-19. Hipertens Riesgo Vasc. 2021 Feb 13:S1889-1837(21)00015-5 [doi
  33. San Román JA, et al. La presencia de cardiopatía agrava el pronóstico de los pacientes con COVID-19. Rev Esp Cardiol. 2020 Sep;73(9):773-775 [doi
  34. Bonanad C, et al. Principales desafíos del desequilibrio electrolítico en pacientes geriátricos con COVID-19 y riesgo de prolongación del intervalo QT. Respuesta. Rev Esp Cardiol. 2021 Feb;74(2):199-200 [doi
  35. García-Rodríguez D, et al. Prolongación del intervalo QT por fármacos en la neumonía por COVID-19: influencia en la supervivencia durante el ingreso. Rev Esp Cardiol. 2021 Jan;74(1):111-112 [doi
  36. Marsico S, et al. Pulmonary infarction secondary to pulmonary thromboembolism in COVID-19 diagnosed with dual-energy CT pulmonary angiography. Rev Esp Cardiol (Engl Ed). 2020;73(8):672-674 [doi
  37. Romaguera R, et al. Reducción de los ingresos por infarto agudo de miocardio con elevación del segmento ST en Cataluña durante la pandemia de COVID-19. Rev Esp Cardiol. 2020 Sep;73(9):778-780 [doi
  38. León AC, et al. Síndrome coronario agudo y shock en contexto de infección aguda por COVID-19. Rev Esp Cardiol. 2020 May 15;10.1016/j.recesp.2020.05.005 [doi]
  39. Oyarzabal L, et al. Síndrome de tako-tsubo asociado con COVID-19. Rev Esp Cardiol. 2020 Oct;73(10):846 [doi
  40. García-Cosío MD, et al. Trasplante cardiaco durante la pandemia de la COVID-19: organización asistencial y características de los pacientes infectados. Rev Esp Cardiol. 2020 Dec;73(12):1077-1080 [doi
  41. Jiménez ZG, et al. Tromboembolismo pulmonar durante la pandemia de la COVID-19 con sospecha diagnóstica desde atención primaria. FMC. 2020 Aug-Sep;27(7):371-372 [doi
  42. Alcoberro Torres L, et al. Trombo en la aurícula derecha tras neumonía por COVID-19. Rev Esp Cardiol (Engl Ed). 2020 Oct;73(10):845 [doi
  43. Ioan AM, et al. Tromboembolia pulmonar en la COVID-19. Cuando nada es lo que parece. Rev Esp Cardiol. 2020 Aug;73(8):665-667 [doi
  44. Piera Carbonell A, et al. Trombosis y COVID-19: Atención Primaria clave en el abordaje interdisciplinar. Semergen. 2020 Jun 6;S1138-3593(20)30194-5 [doi
  45. Segura de la Cal T, et al. Unexpected Favourable Course of Coronavirus Disease 2019 in Chronic Thromboembolic Pulmonary Hypertension Patients. Arch Bronconeumol. 2020 Nov;56(11):749-752 [doi
  46. García-Fernández A, et al. Usefulness and safety of self-electrocardiographic monitoring during treatment with hydroxychloroquine and azithromycin in COVID-19 patients. Rev Esp Cardiol (Engl Ed). 2021 Jan;74(1):108-111 [doi
  47. García-Fernández A, et al. Utilidad y seguridad de la automonitorización electrocardiográfica durante el tratamiento con hidroxicloroquina y azitromicina en pacientes con COVID-19. Rev Esp Cardiol. 2021 Jan;74(1):108-111 [doi

Cirugía

  1. Pardo Aranda F. About the scientific letter ‘Suspected acute abdomen as an extrapulmonary manifestation of COVID-19 infection’. Cir Esp. 2020 Aug-Sep;98(7):423-424 [doi
  2. Blanco-Colino R, et al. Authors response to: «About the scientific letter: Suspected Acute Abdomen as an Extrapulmonary Manifestation of Covid-19 Infection». Cir Esp. 2020 Aug-Sep;98(7):424-425 [doi
  3. Bernabeu García A, et al. Cholecystitis enfisematous suspected SARS-CoV-2 infection. Cir Esp. 2020 Aug 4:S0009-739X(20)30260-8 [doi
  4. Lacy AM, et al. Considerations for transanal total mesorectal excision (TaTME) use during the COVID-19 pandemic. Br J Surg. 2020 May 8;10.1002/bjs.11685 [doi]
  5. García Virosta M, et al. Diagnostic Delay During the COVID-19 Pandemic: Liver Abscess Secondary to Acute Lithiasic Cholecystitis. Cir Esp. 2020 Aug-Sep;98(7):409 [doi
  6. Vicario Bravo M, et al. Digestive symptoms and COVID-19: Importance of ruling out associated surgical pathology. Cir Esp (Engl Ed). 2021 May;99(5):385-387 [doi]
  7. Ruiz de Angulo D, et al. Influence of the lockdown due to COVID-19 on weight-loss results during the first year after sleeve gastrectomy. Cir Esp. 2021 Jun-Jul;99(6):428-432 [doi
  8. Gemio del Rey IA, et al. Neumoperitoneo espontáneo no quirúrgico en paciente COVID-19 positivo con neumonía bilateral severa. Cir Esp. 2020 Jun 10;S0009-739X(20)30204-9 [doi
  9. Gemio Del Rey IA, et al. Non-surgical spontaneous pneumoperitoneum in a COVID-19 positive patient with severe bilateral pneumonia. Cir Esp. 2021 Jun-Jul;99(6):469-471 [doi
  10. Gonzálvez Guardiola P,et al. Perforación intestinal en paciente COVID-19 en tratamiento con tocilizumab y corticoides. A propósito de un caso. Cir Esp. 2021 Feb;99(2):156-157 [doi
  11. Gómez Sánchez J, et al. Response to «Emphysematous cholecystitis in suspected SARS-CoV-2 infection». Cir Esp (Engl Ed). 2021 Feb;99(2):167-168 [doi
  12. Páramo-Zunzunegui J, et al. Severe Clostridium difficile colitis as potential late complication associated with COVID-19. Ann R Coll Surg Engl. 2020 Sep;102(7):e176-e179 [doi
  13. Blanco-Colino R, et al. Sospecha de abdomen agudo como manifestación extrapulmonar de infección por Covid-19. Cir Esp. 2020 May;98(5):295-296 [doi
  14. Pardo Aranda F. A propósito de la carta científica «Sospecha de abdomen agudo como manifestación extrapulmonar de infección COVID-19». Cir Esp. 2020 Apr 22;S0009-739X(20)30138-X [doi]

Cirugía cardíaca

  1. Rodríguez-Fuster A, et al. Tracheal Trauma in the Context of the Current Infection by COVID-19. About 2 Cases. Arch Bronconeumol. 2020 Oct;56(10):670-671 [doi] 

Cirugía torácica

  1. Martínez-Téllez E, et al. Tracheotomy in patients COVID-19: A necessary high risk procedure. Two center experience. Arch Bronconeumol. 2020 Oct;56(10):673-674 [doi

Cuidados intensivos

  1. Escudero D, et al. Análisis de SARS-CoV-2 en el aire de una UCI dedicada a pacientes covid-19. Med Intensiva (Engl Ed). 2021 May;45(4):247-250 [doi
  2. Serrano-Martínez JL, et al. Characteristics and results of a series of 59 patients with severe pneumonia due to COVID-19 admitted in the ICU. Med Intensiva. 2020 Dec;44(9):580-583 [doi
  3. Franch-Llasat D, et al. e-Thrombosis in the COVID-19 era: collateral effects of confinement. Med Intensiva. 2021 Mar;45(2):122-124 [doi
  4. Peiro Chamarro M, et al. Histolo-radiological dissociation in pulmonary fibrosis secondary to SARS-CoV-2 infection. Med Intensiva. 2020 Jul 11:S0210-5691(20)30248-5 [doi
  5. Carrasco G, et al. ICU decision making based on Living Systematic Review strategy during SARS-CoV-2 pandemic. Results of a prospective case serie. Med Intensiva. 2020 Nov;44(8):516-519 [doi
  6. Vela Colmenero RM, et al. Peripheral pulmonary thromboembolism in COVID-9 bilateral pneumonia. Med Intensiva. 2020 Aug 26:S0210-5691(20)30260-6 [doi
  7. Sirvent JM, et al. Predictive biomarkers of mortality in critically ill patients with COVID-19. Med Intensiva (Engl Ed). 2020 Nov 10:S0210-5691(20)30334-X [doi
  8. Esteban Molina A, et al. SARS-CoV-2, A new causative agent of Guillain-Barré syndrome? Med Intensiva. 2020 Sep 6:S0210-5691(20)30274-6 [doi
  9. González Moyano AB, et al. SARS-CoV-2 or Pnuemocystis jirovecii? A case report. Med Intensiva. 2021 Mar;45(2):124-126 [doi
  10. Esteban Molina A, et al. Síndrome de Guillain-Barré asociado a infección por COVID-19. Med Intensiva. 2020 Nov;44(8):513-514 [doi
  11. González-Castro A, et al. Síndrome post-cuidados intensivos después de la pandemia por SARS-CoV-2. Med Intensiva. 2020 Nov;44(8):522-523 [doi
  12. Chalela R, et al. Thrombus in transit in patient with COVID-19 pneumonia. Med Intensiva. 2020 Nov;44(8):524 [doi
  13. Franqueza JL, et al. When success means focusing on the oxygen delivery. A case of conventional management of severe hypoxemia in SARS-CoV-2. Med Intensiva. 2020 Jun 17;S0210-5691(20)30183-2 [doi

Dermatología

  1. García-Gil MF, et al. Acral purpuric lesions (Erythema multiforme type) associated with thrombotic vasculopathy in a child during the COVID-19 pandemic. J Eur Acad Dermatol Venereol. 2020 Sep;34(9):e443-e445 [doi]
  2. Roca-Ginés J, et al. Assessment of Acute Acral Lesions in a Case Series of Children and Adolescents During the COVID-19 Pandemic. JAMA Dermatol. 2020 Sep 1;156(9):992-997 [doi
  3. Porcar Saura S, et al. Attitudes of Patients With Skin Tumors During the COVID-19 Pandemic. Actas Dermosifiliogr. 2021 Feb;112(2):195-198 [doi
  4. Romaní J, et al. Chilblain and Acral Purpuric Lesions in Spain during Covid Confinement: Retrospective Analysis of 12 Cases. Actas Dermosifiliogr (Engl Ed). 2020 Jun;111(5):426-429 [doi
  5. López-Robles J, et al. Chilblain-like lesions: a case series of 41 patients during the COVID-19 pandemic. Clin Exp Dermatol. 2020 May 5;10.1111/ced.14275 [doi]
  6. Feito-Rodríguez M, et al. Chilblain-like lesions and COVID-19 infection: A prospective observational study at Spain’s ground zero. J Am Acad Dermatol. 2021 Feb;84(2):507-509 [doi
  7. Galván Casas C, et al. Classification of the cutaneous manifestations of COVID-19: a rapid prospective nationwide consensus study in Spain with 375 cases. Br J Dermatol. 2020 Apr 29;10.1111/bjd.19163 [doi]
  8. Fernandez-Nieto D, et al. Clinical and histological characterization of vesicular COVID-19 rashes: A prospective study in a tertiary care hospital. Clin Exp Dermatol. 2020 May 8;10.1111/ced.14277 [doi]
  9. Herrero-Moyano M, et al. A clinicopathological study of 8 patients with COVID-19 pneumonia and a late-onset exanthema. J Eur Acad Dermatol Venereol. 2020 Sep;34(9):e460-e464 [doi]
  10. Santonja C, et al. COVID-19 chilblain-like lesion: immunohistochemical demonstration of SARS-CoV-2 spike protein in blood vessel endothelium and sweat gland epithelium in a polymerase chain reaction-negative patient. Br J Dermatol. 2020 Oct;183(4):778-780 [doi
  11. Queiro Silva R, et al. COVID-19 patients with psoriasis and psoriatic arthritis on biologic immunosuppressant therapy versus apremilast in North Spain. Dermatol Ther. 2020 Jul 3;e13961 [doi
  12. Obaya Rebollar JC. Cutaneous manifestations of COVID infection 19. About a case. Med Clin (Barc). 2020 Jul 10;155(1):50 [doi]
  13. Leis-Dosil VM, et al. Eosinophilic Panniculitis Associated With COVID-19. Actas Dermosifiliogr. 2020 Nov;111(9):804-805 [doi
  14. Monte Serrano J, et al. Eritema multiforme inducido por hidroxicloroquina en paciente con COVID-19. Med Clin (Barc). 2020;S0025-7753(20)30280-3 [doi
  15. Sánchez-Velázquez A, et al. Erythema multiforme in the context of SARS-Coronavirus-2 infection. Med Clin (Barc). 2020 Aug 14;155(3):141 [doi
  16. Tejera-Vaquerizo A, et al. Estimated effect of COVID-19 lockdown on melanoma thickness and prognosis: a rate of growth model. J Eur Acad Dermatol Venereol. 2020 May 2;10.1111/jdv.16555 [doi]
  17. Novo de Matos J, et al. Exantema palmar por el nuevo coronavirus SARS-CoV-2. Med Clin (Barc). 2020 Oct 23;155(8):371 [doi
  18. Pérez-Suárez B, et al. Hallazgos cutáneos en la pandemia de COVID-19 en la Región de Murcia. Med Clin (Barc). 2020 May 8;S0025-7753(20)30264-5 [doi]
  19. Monte Serrano J, et al. Hydroxychloroquine-induced erythema multiforme in a patient with COVID-19. Med Clin (Barc). 2020 Sep 11;155(5):231 [doi
  20. Fernández Canedo MI, et al. Impact of the SARS-CoV-2 pandemic on the early diagnosis of melanoma. Med Clin (Barc). 2021 Jan 28:S0025-7753(21)00019-1 [doi
  21. Monte Serrano J, et al. Lesiones cutáneas acro-isquémicas durante la epidemia COVID-19. Semergen. 2020 Aug;46 Suppl 1:103-105 [doi]
  22. Gimeno Castillo J, et al. Liquen plano en una paciente tras SARS-CoV-2 tratado con lopinavir/ritonavir. Med Clin (Barc). 2021 Jan 28:S0025-7753(21)00028-2 [doi
  23. Falkenhain López D, et al. Maculopapular rash as initial manifestation of SRAS-coronavirus-2 infection. Med Clin (Barc). 2020 Jul 24;155(2):92 [doi
  24. Morey-Olivé M, et al. Manifestaciones cutáneas en contexto del brote actual de enfermedad por coronavirus 2019. An Pediatr (Barc). 2020 Jun;92(6):374-375 [doi
  25. Andina-Martinez D, et al. Mucocutaneous manifestations in children hospitalized with COVID-19. J Am Acad Dermatol. 2021 Jul;85(1):88-94 [doi
  26. Sáenz Aguirre A, et al. Novel outbreak of acral lesions in times of COVID-19: A description of 74 cases from a tertiary university hospital in Spain. Clin Exp Dermatol. 2020 Dec;45(8):1065-1067 [doi]
  27. Martín Enguix D, et al. Pityriasis rosea Gibert type rash in an asymptomatic patient that tested positive for COVID-19. Med Clin (Barc). 2020 Sep 25;155(6):273 [doi
  28. Goren A, et al. A preliminary observation: Male pattern hair loss among hospitalized COVID-19 patients in Spain – A potential clue to the role of androgens in COVID-19 severity. J Cosmet Dermatol. 2020;19(7):1545-1547 [doi
  29. Cabrera Hernández R, et al. SARS-CoV-2, skin lesions and the need of a multidisciplinary approach. J Eur Acad Dermatol Venereol. 2020 Jun 13;10.1111/jdv.16745 [doi]
  30. Crespo Sabarís R, et al. SARS-CoV-2: una presentación peculiar. Semergen. 2020 May 8;S1138-3593(20)30140-4 [doi]
  31. García-Martínez FJ, et al. SARS-CoV-2 and EBV coinfection. Med Clin (Barc). 2020 Oct 9;155(7):319-320 [doi
  32. Redondo-Sendino Á, et al. Skin manifestations associated with the new coronavirus SARS-CoV-2 disease. Med Clin (Barc). 2020 Nov 13;155(9):414-415 [doi
  33. De Perosanz-Lobo D, et al. Urticarial vasculitis in COVID-19 infection: a vasculopathy-related symptom? J Eur Acad Dermatol Venereol. 2020 Oct;34(10):e566-e568 [doi

Endocrinología

  1. Arrieta Blanco F, et al. GLUT1 and COVID-19 deficiency syndrome. Endocrinol Diabetes Nutr. 2020 Sep 1:S2530-0164(20)30165-8 [doi
  2. Barahona San Millán R, et al. Painless thyroiditis in SARS-CoV-2 infection. Endocrinol Diabetes Nutr. 2020 Oct 13:S2530-0164(20)30203-2 [doi
  3. Ruano R, et al. Subacute thyroiditis might be a complication triggered by SARS-CoV-2. Endocrinol Diabetes Nutr. 2020 Oct 13:S2530-0164(20)30206-8 [doi

Enfermedades raras

  1. Andrade-Campos M, et al. Direct and indirect effects of the SARS-CoV-2 pandemic on Gaucher Disease patients in Spain: Time to reconsider home-based therapies? Blood Cells Mol Dis. 2020 Jul 14;85:102478. [doi

Geriatría

  1. González-Silva Y, et al. Afectación clínica y sintomatológica en pacientes mayores de 65 años por COVID-19. Aten Primaria. 2020 Nov;52(9):662-664 [doi]
  2. García-de Castro A, et al. Infección SARS-CoV-2 en una residencia de mayores en la primera ola pandémica. Rev Esp Geriatr Gerontol. 2021 Feb 5:S0211-139X(21)00007-X [doi
  3. Mas Maresma L, et al. Miastenia gravis asociada a la infección por SARS-CoV-2: una conjunción de factores. Rev Esp Geriatr Gerontol. 2020 Nov-Dec;55(6):360-361 [doi
  4. Gala Serra C. Paciente anciano y sus complicaciones por infección por COVID-19. Rev Esp Geriatr Gerontol. 2020 Nov-Dec;55(6):365-366 [doi
  5. Martín Pozuelo Ruiz de Pascual R, et al. Pancytopenia during SARS-CoV-2 infection. Med Clin (Barc). 2020 Oct 23;155(8):364-365 [doi
  6. Peña-Lora DY, et al. Uso de ozonoterapia rectal en paciente anciana con neumonía grave por COVID-19. Rev Esp Geriatr Gerontol. 2020 Nov-Dec;55(6):362-364 [doi

Hematología

  1. Franch Sarto M, et al. Aumento de la gravedad de las hemopatías malignas agudas diagnosticadas durante la pandemia COVID-19. Med Clin (Barc). 2020 Jun 12;S0025-7753(20)30357-2 [doi
  2. García-Erce JA, et al. Blood Donations and Transfusions during the COVID-19 Pandemic in Spain: Impact According to Autonomous Communities and Hospitals. Int J Environ Res Public Health. 2021 Mar 27;18(7):3480 [doi
  3. Lozano R, et al. Incidence of heparin-induced thrombocytopenia in patients with 2019 coronavirus disease. Med Clin (Barc). 2020 Nov 13;155(9):409-410 [doi
  4. Piñana JL, et al. Seasonal Human Coronavirus Respiratory Tract Infection in Recipients of Allogeneic Hematopoietic Stem Cell Transplantation. J Infect Dis. 2021 May 20;223(9):1564-1575 [doi]

Medicina Intensiva

  1. Escudero D, et al. Analysis of SARS-CoV-2 in the air of an ICU dedicated to covid-19 patients. Med Intensiva. 2021 May;45(4):247-250 [doi]
  2. Serrano-Martínez JL, et al. Características y resultados de una serie de 59 pacientes con neumonía grave por COVID-19 ingresados en UCI. Med Intensiva. 2020 Jun 17;S0210-5691(20)30184-4 [doi
  3. Lobo-Valbuena B, et al. Characteristics of critical patients with COVID-19 in a Spanish second-level hospital. Med Intensiva. 2021 Jan-Feb;45(1):56-58 [doi
  4. Álvarez Fernández M, et al. COVID-19 associated pulmonary aspergillosis. Med Intensiva. 2020 Sep 6:S0210-5691(20)30277-1 [doi
  5. Carrasco G, et al. Decisiones en UCI basadas en la estrategia Living Systematic Review durante la pandemia de SARS-CoV-2. Resultados de una serie prospectiva de casos. Med Intensiva. 2020 Jun 11;S0210-5691(20)30172-8 [doi
  6. Belenguer Muncharaz A, et al. Effectiveness of non-invasive ventilation in intensive care unit admitted patients due to SARS-CoV-2 pneumonia. Med Intensiva. 2020 Sep 4:S0210-5691(20)30276-X [doi
  7. Blanco-Schweizer P, et al. Interhospital transport of COVID-19 patients on ECMO and comparison with historic controls. Med Intensiva. 2020 Oct 9:S0210-5691(20)30323-5 [doi
  8. Fernández García L, et al. Relación entre obesidad, diabetes e ingreso en UCI en pacientes COVID-19. Med Clin (Barc). 2020 Jun 25;S0025-7753(20)30398-5 [doi
  9. Vela Colmenero RM, et al. Spontaneous pneumothorax and pneumomediastinum in bilateral pneumonia due to COVID-19. Med Intensiva. 2020 Dec;44(9):591-592 [doi

Medicina Interna

  1. García-Martínez FJ, et al. Coinfección por SARS-CoV-2 y virus Epstein-Barr. Med Clin (Barc). 2020 Jun 25;S0025-7753(20)30406-1 [doi]
  2. Molina-Iturritza E, et al. Coronavirus disease 2019 in patients with HIV in the province of Araba, Basque Country, Spain. AIDS. 2020 Sep 1;34(11):1696-1697 [doi
  3. Lozano Parras MA, Amann Arévalo M, Ciller Martínez M, Culebras López E. COVID-19 and influenza A coinfection: a matter of principle. Enferm Infecc Microbiol Clin. 2020 Jul 16:S0213-005X(20)30249-4 [doi
  4. Cucurull-Canosa J, et al. Description of 12 HIV-positive patients who have had the COVID-19 in our area. Enferm Infecc Microbiol Clin. 2021 Apr;39(4):208-210 [doi
  5. Vizcarra P, et al. Description of COVID-19 in HIV-infected individuals: a single-centre, prospective cohort. Lancet HIV. 2020 May 28;S2352-3018(20)30164-8 [doi]
  6. Tung-Chen Y, et al. Dolor torácico persistente tras resolución de la enfermedad por coronavirus 2019 (COVID-19). Semergen. 2020 Aug;46 Suppl 1:88-90 [doi
  7. Guillén L, et al. Dyspnea and pleuritic chest pain during the COVID-19 pandemic. Enferm Infecc Microbiol Clin. 2021 Jan;39(1):41-42 [doi
  8. Pintos-Pascual I, et al. Eosinophilia and abdominal pain after severe pneumonia due to COVID 19. Enferm Infecc Microbiol Clin (Engl Ed). 2020 Nov 10:S0213-005X(20)30332-3 [doi]
  9. Ferra Murcia S, et al. Febrile syndrome upon return from the tropics during the COVID-19 pandemic. Enferm Infecc Microbiol Clin (Engl Ed). 2020 Nov 6:S0213-005X(20)30331-1 [doi]
  10. Fernández-Raga S, et al. Spontaneous neumomediastin in coronavirus-associated pneumonitis. Med Clin (Barc). 2020 Nov 13;155(9):421 [doi] 
  11. Fernández Miró M, et al. Syndrome of inappropriate antidiuretic hormone secretion associated with a SARS-CoV-2 pneumonia. Med Clin (Barc). 2021 Feb 26;156(4):195-196 [doi]
  12. Lalueza A, et al. Utilidad de las escalas de sepsis para predecir el fallo respiratorio y la muerte en pacientes con COVID-19 fuera de las Unidades de Cuidados Intensivos. Rev Clin Esp. 2020 Nov 7 [doi]

Medicina nuclear

  1. Gómez-Caminero-López F, et al. Neumonía vírica bilateral por COVID-19 como hallazgo casual en 18F-FDG-PET-TC de estadificación de paciente con melanoma gemelar derecho. Rev Esp Med Nucl Imagen Mol. 2020 Sep-Oct;39(5):316-317 [doi]

Microbiología

  1. Pemán J, et al. Fungal co-infection in COVID-19 patients: Should we be concerned? Rev Iberoam Micol. 2020 Apr-Jun;37(2):41-46 [doi

Nefrología

  1. Shabaka A, et al. Acute kidney injury and nephrotic syndrome secondary to COVID-19-associated focal segmental glomerulosclerosis. Nefrologia. 2021 Jan 23:S0211-6995(21)00007-2 [doi
  2. Albalate M, et al. Alta prevalencia de COVID-19 asintomático en hemodiálisis. Aprendiendo día a día el primer mes de pandemia de COVID-19. Nefrologia. 2020 Apr 30;S0211-6995(20)30043-6 [doi]
  3. Goicoechea M, et al. COVID-19: clinical course and outcomes of 36 hemodialysis patients in Spain. Kidney Int. 2020;98(1):27-34 [doi]
  4. Goicoechea M, et al. COVID-19: Clinical course and outcomes of 36 maintenance hemodialysis patients from a single center in Spain. Kidney Int. 2020 May 10;S0085-2538(20)30509-3 [doi]
  5. Baldallo C, et al. COVID-19 in a patient with hypocomplementemic urticarial syndrome and MPO-ANCA vasculitis on hemodialysis treated with omalizumab. Nefrologia. 2021 May-Jun;41(3):354-356 [doi
  6. De la Flor Merino JC, et al. COVID-19 in chronic hemodialysis patients: A report of 9 cases in Madrid, Spain. Clin Nephrol. 2021 Jan;95(1):45-53 [doi
  7. Cuevas Tascón GC, et al. Infarto renal en paciente con COVID -19. Nefrologia. 2021 Jan-Feb;41(1):84-87 [doi]
  8. De la Flor Merino JC, et al. Inusual caso de hiponatremia aguda grave en paciente con infección por COVID-19. Nefrologia. 2020;40(3):356-358 [doi
  9. De Lorenzo A, et al. Ischaemic stroke associated with COVID-19 in dialysis patients. Nefrologia. 2020 Oct 8:S0211-6995(20)30134-X [doi
  10. Marcilla Vázquez C, et al. Microangiopatía trombótica: manifestación renal en la enfermedad por SARS-CoV-2 (COVID-19). An Pediatr (Barc). 2020 Nov;93(5):352-353 [doi
  11. Santana Quintana A, et al. Not all cytokin storms are due to COVID-19: Hemophagotic syndrome with renal involvement secondary to extranasal lymphoma and Epstein-Barr virus. A case report during the pandemic. Nefrologia (Engl Ed). 2021 May-Jun;41(3):347-349 [doi]
  12. Valga F, et al. Un nuevo síndrome inflamatorio-microtrombótico como explicación para las complicaciones trombóticas en pacientes con COVID-19. Rev Esp Cardiol. 2021 Jan;74(1):115-116 [doi
  13. Valga F, et al. Papel de la hemodiálisis extendida en COVID-19: a propósito de un caso. Nefrologia. 2020 Jul-Aug;40(4):487-490 [doi]
  14. Sandino Pérez J, et al. Pericarditis secondary to COVID-19 infection in a kidney transplant recipient. Nefrologia (Engl Ed). 2021 May-Jun;41(3):349-352 [doi]
  15. Cruzado Vega LL, et al. SARS-CoV-2 and Aspergillus pneumonia in kidney transplantation: More frequent than we think? Nefrologia. 2021 Jan 23:S0211-6995(21)00011-4 [doi
  16. Hernando T, et al. SARS-CoV-2 Infection in Hospitalized Patients with Kidney Disease. Kidney Int Rep. 2020 May 1;10.1016/j.ekir.2020.04.024 [doi]
  17. Sánchez-Álvarez JE, et al. Situación de la infección por SARS-CoV-2 en pacientes en tratamiento renal sustitutivo. Informe del Registro COVID-19 de la Sociedad Española de Nefrología (SEN). Nefrologia. 2020 Apr 16;S0211-6995(20)30040-0 [doi]

Neonatología

  1. González Brabin A, et al. Apnea neonatal como manifestación inicial de infección por SARS-CoV-2. An Pediatr (Barc). 2020 Sep;93(3):215-216 [doi
  2. Chacón-Aguilar R, et al. COVID-19: síndrome febril y clínica neurológica en neonato. An Pediatr (Barc). 2020;92(6):373-374 [doi
  3. Alonso Díaz C, et al. Primer caso de infección neonatal por SARS-CoV-2 en España. An Pediatr (Barc). 2020;92(4):237-238 [doi

Neumología

  1. Ruiz de Gopegui Miguelena P, et al. Afectación endotelial por COVID-19 en criobiopsia pulmonar. Arch Bronconeumol. 2020 Jul 4;S0300-2896(20)30211-8 [doi]
  2. Cardoso A, et al. Bird Fancier’s Lung Diagnosis in Times of COVID-19. Arch Bronconeumol. 2021 Jan;57 Suppl 1:90-91 [doi]
  3. García Clemente M, et al. Can SARS-CoV-2 be a Risk Factor for Pulmonary Aspergillosis? Arch Bronconeumol. 2021 Jan;57 Suppl 1:72-73 [doi
  4. Figueira Gonçalves JM, et al. Clinical challenges in chronic obstructive pulmonary disease in patients who suffered SARS-CoV-2 infection. Med Clin (Barc). 2020 Aug 28;155(4):162-164 [doi
  5. Tarrasó Castillo J, et al. COVID-19: New disease, new manifestations. Arch Bronconeumol. 2020 Dec;56(12):825-826 [doi]
  6. Ruiz de Gopegui Miguelena P, et al. Covid-19-Related Endothelial Injury in Lung Cryobiopsy. Arch Bronconeumol. 2021 Jan;57 Suppl 1:65 [doi
  7. Gómez Rebollo C, et al. COVID and CARE®. Mobile application for monitoring SARS-CoV-2 positive patients after hospitalization. Enferm Infecc Microbiol Clin (Engl Ed). 2021 May;39(5):261-262 [doi]
  8. Guillén L, et al. Dyspnea and pleuritic chest pain during the COVID-19 pandemic. Enferm Infecc Microbiol Clin. 2020 Jul 4;S0213-005X(20)30240-8 [doi
  9. Mendoza Ferradas FJ, et al. Extensión y cuantificación de la carga inflamatoria en COVID-19 mediante tomografía computarizada. Arch Bronconeumol. 2020;56 Suppl 2:31-32 [doi]
  10. Mariscal Aguilar P, et al. Imágenes quísticas pulmonares en paciente con infección por SARS-CoV-2. Med Clin (Barc). 2020 Jun 25;S0025-7753(20)30404-8 [doi
  11. Mariscal Aguilar P, et al. Lung cysts in a patient with SARS-CoV-2. Med Clin (Barc). 2020 Oct 9;155(7):325 [doi
  12. Yang B, et al. Lung Herniation Mimicking COVID-19. Arch Bronconeumol. 2020;56 Suppl 2:35 [doi
  13. López Zúñiga MÁ, et al. Neumomediastino espontáneo en pacientes con COVID-19. Emergencias. 2020;32(4):298-299
  14. Marsico S, et al. Neumotórax espontáneo en pacientes con covid-19. Arch Bronconeumol. 2021 Jan;57 Suppl 1:66 [doi
  15. Déniz-Armengol C, et al. Paciente con neumonía COVID-19: hallazgos quirúrgicos y correlación radiológica de las lesiones pulmonares. Arch Bronconeumol. 2020;56 Suppl 2:33 [doi
  16. Laviña Soriano E, et al. Pleural Effusion Secondary to Atrial Perforation During COVID-19 Period. Arch Bronconeumol. 2021 Jan;57 Suppl 1:88-90 [doi]
  17. Segrelles-Calvo G, et al. Prevalence of opportunistic invasive aspergillosis in COVID-19 patients with severe pneumonia. Mycoses. 2021 Feb;64(2):144-151 [doi
  18. Tabernero Huguet E, et al. Pulmonary Function in Early Follow-up of patients with COVID-19 Pneumonia. Arch Bronconeumol. 2021 Jan;57 Suppl 1:75-76 [doi
  19. Isea de la Viña J, et al. Situación clínica de infección por SARS-CoV-2 en pacientes con carcinoma broncogénico: contexto actual. Arch Bronconeumol. 2020 Mar 31;S0300-2896(20)30098-3 [doi]
  20. Ríos-Barnés M, et al. The Spectrum of COVID-19 Disease in Adolescents. Arch Bronconeumol. 2021 Jan;57 Suppl 1:84-85 [doi
  21. Marsico S, et al. Spontaneous Pneumomediastinum and Macklin Effect in COVID-19 Patients. Arch Bronconeumol. 2021 Jan;57 Suppl 1:67 [doi
  22. Gorospe L, et al. Spontaneous Pneumomediastinum in Patients With COVID-19: A Case Series of Four Patients. Arch Bronconeumol. 2020 Nov;56(11):754-756 [doi
  23. Juárez-Lloclla JP, et al. Spontaneous Pneumopericardium and Pneumomediastinum in Twelve COVID-19 Patients. Arch Bronconeumol. 2021 Jan;57 Suppl 1:86-88 [doi
  24. Del Campo F, et al. Study of the Adherence to continuous positive airway pressure Treatment in Patients with Obstructive Sleep Apnea Syndrome in the Confinement During the COVID-19 Pandemic. Arch Bronconeumol. 2020 Dec;56(12):818-819 [doi
  25. Pérez Acosta G, et al. Traqueobronquitis necrotizante con obstrucción del tubo endotraqueal en pacientes COVID-19. Rev Clin Esp. 2020 May 15;10.1016/j.rce.2020.05.002 [doi]
  26. Gómez-Hernández MT, et al. Twice Lucky: Elderly Patient Surviving Both COVID-19 and Serendipitous Lung Carcinoma. Arch Bronconeumol. 2020 Dec;56(12):826-828 [doi

Neurocirugía

  1. Rascón-Ramírez FJ, et al. Supra and infratentorial massive strokes in previously healthy young patients with SARS-CoV-2. The role of neurosurgery. Neurocirugia (Astur). 2020 Sep 6:S1130-1473(20)30098-1 [doi

Neurología

  1. Méndez-Guerrero A, et al. Acute hypokinetic-rigid syndrome following SARS-CoV-2 infection. Neurology. 2020 Oct 13;95(15):e2109-e2118 [doi
  2. Montero-Escribano P, et al. Anti-CD20 and COVID-19 in multiple sclerosis and related disorders: A case series of 60 patients from Madrid, Spain. Mult Scler Relat Disord. 2020 May 7;42:102185 [doi]
  3. Álvarez Bravo G, et al. Anti-NMDA receptor encephalitis secondary to SARS-CoV-2 infection. Neurologia. 2020 Nov-Dec;35(9):699-700 [doi
  4. Ramos-Pachón A, et al. Bottlenecks in the Acute Stroke Care System during the COVID-19 Pandemic in Catalonia. Cerebrovasc Dis. 2021 May 21:1-9 [doi]
  5. Porta-Etessam J, et al. Brain inflammatory thrombogenic vasculopathy related with SARS-CoV-2 infection. Neurologia. 2020 Nov-Dec;35(9):701-703 [doi
  6. Reyes-Bueno JA, et al. Case fatality of COVID-19 in patients with neurodegenerative dementia. Neurologia. 2020 Nov-Dec;35(9):639-645 [doi
  7. Ballvé-Martín A, et al. Complicación trombótica de neumonía grave por COVID-19: ictus por embolismo paradójico atípico. Rev Neurol. 2020 Sep 1;71(5):186-190 [doi
  8. Carod-Artal FJ. Complicaciones neurológicas por coronavirus y COVID-19. Rev Neurol. 2020;70(9):311‐322 [doi]
  9. Peña-Salazar C, et al. Convulsive status epilepticus as a possible symptom of COVID-19 in a patient with intellectual disability and autistic spectrum disorder. Neurologia. 2020 Nov-Dec;35(9):703-705 [doi
  10. Romero Cantero V, et al. COVID-19 y neuroinfecciones concomitantes. Neurologia. 2020;35(5):332-333 [doi]
  11. Serrano-Serrano B, et al. Encefalitis multifocal como manifestación neurológica de la infección por COVID-19. Rev Neurol. 2020 Nov 1;71(9):351-352 [doi
  12. Conde Blanco E, et al. Epilepsy and lockdown: A survey of patients normally attending a Spanish centre. Acta Neurol Scand. 2021 Feb;143(2):206-209 [doi
  13. Rábano-Suárez P, et al. Generalized myoclonus in COVID-19. Neurology. 2020 Aug 11;95(6):e767-e772 [doi
  14. García-Manzanedo S, et al. Guillain-Barré syndrome after covid-19 infection. Med Clin (Barc). 2020 Oct 23;155(8):366 [doi
  15. Barrachina-Esteve O, et al. Guillain-Barré syndrome as the first manifestation of SARS-CoV-2 infection. Neurologia. 2020 Nov-Dec;35(9):710-712 [doi
  16. Hernández Pérez I, et al. Isolated syncope as a form of presentation of COVID-19 infection. Neurologia (Engl Ed). 2021 Mar;36(2):185-187 [doi
  17. Gutiérrez-Ortiz C, et al. Miller Fisher syndrome and polyneuritis cranialis in COVID-19. Neurology. 2020 Aug 4;95(5):e601-e605 [doi
  18. Castillo Álvarez F, et al. Riesgo de infección por SARS-CoV-2 y resultados clínicos en pacientes con esclerosis múltiple en la Rioja (España). Med Clin (Engl Ed). 2020 Oct 23;155(8):362-363 [doi
  19. Guijarro-Castro C, et al. Síndrome de Guillain-Barré tras infección por SARS-CoV-2. Comentarios tras la publicación de 16 nuevos casos. Neurologia. 2020;35(6):412-415 [doi
  20. Trejo-Gabriel-Galán JM. Ictus como complicación y como factor pronóstico de COVID-19. Neurologia. 2020 May 6;S0213-4853(20)30092-X. [doi]
  21. Álvarez ÁIP, et al. Infección por SARS-CoV-2 asociada a diplopía y anticuerpos antirreceptor de acetilcolina [texto completo]. Neurologia. 2020 Apr 18;S0213-4853(20)30068-2 [doi]
  22. Lopez-Fernández A, et al. Lesión axonal difusa asociada a infección por COVID-19. Med Clin (Barc). 2020 Sep 25;155(6):274-275 [doi
  23. Gutiérrez-Ortiz C, et al. Miller Fisher Syndrome and polyneuritis cranialis in COVID-19. Neurology. 2020 Apr 17:10.1212/WNL.0000000000009619 [doi]  
  24. Abenza Abildúa MJ, et al. Myopathy associated with severe SARS-CoV-2 infection. Neurologia. 2020 Nov-Dec;35(9):706-708 [doi
  25. Romero-Sánchez CM, et al. Neurologic manifestations in hospitalized patients with COVID-19: The ALBACOVID registry. Neurology. 2020 Aug 25;95(8):e1060-e1070 [doi
  26. López-Blanco R, et al. Neuroinfecciones en tiempos de COVID-19 [texto completo]. Neurologia. 2020 Apr 25;S0213-4853(20)30079-7 [doi]
  27. Lara B, et al. Neuropsychiatric symptoms and quality of life in Spanish patients with Alzheimer’s disease during the COVID-19 lockdown. Eur J Neurol. 2020 Sep;27(9):1744-1747 [doi
  28. Pellitero SE, et al. Paciente con clínica neurológica como única manifestación de infección por SARS-Cov-2. Neurologia. 2020 Apr 24;S0213-4853(20)30078-5 [doi]
  29. Casas E, et al. Parálisis facial periférica aislada en un paciente con COVID-19. Rev Neurol. 2020;71(1):40-41 [doi]
  30. García Ochoa-Fernández E, et al. Parálisis facial periférica en un paciente pediátrico sin factores de riesgo en el contexto de infección por SARS-CoV-2. Rev Neurol. 2021 Mar 1;72(5):177-178 [doi
  31. Castillo Álvarez F, et al. Riesgo de infección por SARS-CoV-2 y resultados clínicos en pacientes con esclerosis múltiple en la Rioja (España). Med Clin (Barc). 2020 Jul 9;S0025-7753(20)30444-9 [doi
  32. Redondo-Urda MJ, et al. SARS-CoV-2, nuevo agente causal del síndrome de Guillain-Barré. Rev Neurol. 2020 Oct 1;71(7):275-276 [doi
  33. Galán AV, Saucedo PDS, et al. Síndrome de Guillain Barré asociado a infección por SARS-CoV-2. Neurologia. 2020 Apr 22;S0213-4853(20)30072-4 [doi]
  34. García-Manzanedo S, et al. Síndrome de guillain-barré tras infección por COVID-19. Med Clin (Barc). 2020 Jul 9;S0025-7753(20)30446-2 [doi
  35. Marta-Enguita J, et al. Síndrome de Guillain-Barré fatal tras infección por el virus SARS-CoV-2. Neurologia. 2020 Apr 18;S0213-4853(20)30069-4 [doi]
  36. Diezma-Martín AM, et al. Temblor y ataxia en COVID-19. Neurologia. 2020;35(6):409-410 [doi
  37. Dahl Cruz F, et al. Trombosis venosa cerebral e infección por SARS-CoV-2. Rev Neurol. 2020;70(10):391‐392 [doi]
  38. Hallal-Peche F, et al. Utilidad y valor pronóstico del electroencefalograma en la COVID-19 y la encefalopatía: patrones electroencefalográficos en una serie de casos. Rev Neurol. 2020 Dec 16;71(12):431-437 [doi

Obstetricia y ginecología

  1. Caparros-Gonzalez RA. Consecuencias maternas y neonatales de la infección por coronavirus COVID-19 durante el embarazo: una scoping review. Rev Esp Salud Publica. 2020;94:e202004033
  2. Vila-Candel R, et al. Management of labour, puerperium, and lactation in SARS-CoV-2 positive women. Multicentric study in the Valencian Community. Enferm Clin. 2021 Jan 28:S1130-8621(21)00033-4 [doi

Odontología

  1. Díaz Rodríguez M, et al. Oral manifestations associated to Covid-19. Oral Dis. 2020 jul 22;10.1111/odi.13555 [doi
  2. Martín Carreras-Presas C, et al. Oral vesiculobullous lesions associated with SARS-CoV-2 infection. Oral Dis. 2020 May 5;10.1111/odi.13382 [doi]

Oftalmología

  1. García-Romo E, et al. COVID-19 presenting with nystagmus. Arch Soc Esp Oftalmol (Engl Ed). 2021 Apr;96(4):224-226 [doi
  2. Pascual-Prieto J, et al. Epidemia COVID-19: ¿debe el oftalmólogo estar alerta ante las paresias oculomotoras? Arch Soc Esp Oftalmol. 2020;95(7):361-362 [doi

Oncología

  1. Rogado J, et al. Characteristics and outcome of lung cancer patients and Covid-19 infection in a second-level hospital during the first 3 months of the pandemic. Med Clin (Barc). 2020 Nov 13;155(9):411-413 [doi
  2. Kuderer NM, et al. Clinical impact of COVID-19 on patients with cancer (CCC19): a cohort study. Lancet. 2020 May 28;S0140-6736(20)31187-9 [doi]
  3. De Rojas T, et al. COVID-19 infection in children and adolescents with cancer in Madrid. Pediatr Blood Cancer. 2020 May 8;e28397 [doi]
  4. Petrova D, et al. Implicaciones de la pandemia por COVID-19 sobre el cáncer en España. Med Clin (Barc). 2020 May 8;S0025-7753(20)30261-X. [doi]
  5. Fuentes-Antrás J, et al. A snapshot of COVID-19 infection in patients with solid tumors. Int J Cancer. 2020 Dec 3:10.1002/ijc.33420 [doi

Oncología radioterápica

  1. González Del Portillo E, et al. Pulmonary embolism and acro-ischemia in a lung cancer patient with COVID-19. Med Clin (Barc). 2020 Sep 11;155(5):226-227 [doi

Pediatría

  1. Rosés-Gibert P, et al. Acral lesions in a pediatric population during the COVID-19 pandemic: a case series of 36 patients from a single hospital in Spain. World J Pediatr. 2020 Dec;16(6):629-632 [doi
  2. García-Salido A, et al. CD64, CD11a and CD18 leukocytes expression in children with SARS-CoV-2 multisystem inflammatory syndrome versus children with Kawasaki disease: Similar but not the same. Med Clin (Barc). 2021 Jan 22;156(2):89-91 [doi
  3. Andina D, et al. Chilblains in children in the setting of COVID-19 pandemic. Pediatr Dermatol. 2020 May 9;10.1111/pde.14215 [doi]
  4. García-Salido A, et al. Children in Critical Care Due to Severe Acute Respiratory Syndrome Coronavirus 2 Infection: Experience in a Spanish Hospital. Pediatr Crit Care Med. 2020 Aug;21(8):e576-e580 [doi]
  5. Rodríguez-Fanjul J, et al. Infección horizontal por SARS-COV-2 en tres recién nacidos: también podemos evitar irradiación innecesaria. An Pediatr (Engl Ed). 2020 Oct 28:S1695-4033(20)30452-5 [doi]
  6. Velasco Rodríguez-Belvís M, et al. Infección por SARS-CoV-2 en neonatos menores de 28 días. Serie de casos multicéntrica. An Pediatr (Engl Ed). 2020 Nov 11:S1695-4033(20)30478-1 [doi
  7. Velayos M, et al. Influencia de la pandemia por coronavirus 2 (SARS-Cov-2) en la apendicitis aguda. An Pediatr (Barc). 2020 May 11;S1695-4033(20)30179-X [doi]
  8. Gimeno-Costa R, et al. Insuficiencia respiratoria COVID-19: soporte con ECMO para niños y adultos jóvenes. An Pediatr (Barc). 2020 Sep;93(3):202-205 [doi
  9. Ortiz Madinaveitia S, et al. Lesiones cutáneas en paciente con infección por SARS-COV-2. An Pediatr (Barc). 2020 May 11;S1695-4033(20)30176-4 [doi]
  10. Monte Serrano J, et al. Lesiones cutáneas tipo perniosis durante la epidemia COVID-19. An Pediatr (Barc). 2020 Apr 30;S1695-4033(20)30174-0 [doi]
  11. Sainz T, et al. Lung Ultrasound for Evaluation of COVID-19 in Children. Arch Bronconeumol. 2021 Jan;57 Suppl 1:94-96 [doi]
  12. Morey-Olivé M, et al. Manifestaciones cutáneas en contexto del brote actual de enfermedad por coronavirus 2019. An Pediatr (Barc). 2020 Apr 17;S1695-4033(20)30165-X [doi]
  13. Abril-Pérez C, et al. Perniosis del confinamiento, una vieja conocida en el contexto del COVID-19. An Pediatr (Barc). 2020 Apr 25;S1695-4033(20)30173-9 [doi]
  14. Soriano-Arandes A, et al. Prevalence of asymptomatic SARS-CoV-2 infection in children undergoing hospital screening. Enferm Infecc Microbiol Clin. 2020 Oct 13:S0213-005X(20)30316-5 [doi
  15. Fernández-González SM, et al. SARS-CoV-2 infection as trigger multisystem inflammatory syndrome? Enferm Infecc Microbiol Clin. 2021 May;39(5):262-264 [doi
  16. De Ceano-Vivas M, et al. SARS-CoV-2 infection in ambulatory and hospitalised Spanish children. Arch Dis Child. 2020 May 22;archdischild-2020-319366. [doi]
  17. Melgosa M, et al. SARS-CoV-2 infection in Spanish children with chronic kidney pathologies. Pediatr Nephrol. 2020 May 20;1‐4 [doi]
  18. Cabrero-Hernández M, et al. Severe SARS-CoV-2 Infection in Children With Suspected Acute Abdomen: A Case Series From a Tertiary Hospital in Spain. Pediatr Infect Dis J. 2020 May 26;10.1097/INF.0000000000002777 [doi]
  19. Caro-Patón GL, et al. Shock and Myocardial Injury in Children With Multisystem Inflammatory Syndrome Associated With SARS-CoV-2 Infection: What We Know. Case Series and Review of the Literature. J Intensive Care Med. 2021 Apr;36(4):392-403 [doi
  20. Pérez-Heras I, et al. Two Cases of SARS-CoV-2 Infection in Pediatric Oncohematologic Patients in Spain. Pediatr Infect Dis J. 2020 Nov;39(11):1040-1042 [doi
  21. Pineda Caplliure A, et al. Utilidad de la ecografía torácica en infección neonatal por SARS-CoV-2. An Pediatr (Barc). 2021 Jun;94(6):412-413 [doi

Radiodiagnóstico

  1. Caballeros Lam M, et al. Caracterización de la miocarditis por COVID-19 mediante resonancia magnética cardiaca. Rev Esp Cardiol. 2020 Oct;73(10):863-864 [doi
  2. Calvo I, et al. Digital Tomosynthesis and COVID-19: An Improvement in the Assessment of Pulmonary Opacities. Arch Bronconeumol. 2020 Nov;56(11):761-763 [doi
  3. Gorospe L,et al. COVID-19: Thoracic Diagnostic Interventional Procedures in Troubled Times. Arch Bronconeumol. 2020 Oct;56(10):674-676 [doi
  4. Tung-Chen Y,et al. Lung ultrasound in the frontline diagnosis of COVID-19 infection. Med Clin (Barc). 2020 Sep 11;155(5):232 [doi
  5. Martínez Chamorro E, et al. Pulmonary embolisms in patients with COVID-19: a prevalence study in a tertiary hospital. Radiologia (Engl Ed). 2021 Jan-Feb;63(1):13-21 [doi]

Rehabilitación

  1. Ros Dopico L, et al. Monitoring of the rehabilitation therapy of COVID-19 effort dyspnea. Enferm Infecc Microbiol Clin. 2021 May;39(5):258-259 [doi

Reumatología

  1. Fernandez-Gutierrez B. COVID-19 con afectación pulmonar. Una enfermedad autoinmune de causa conocida [texto completo]. Reumatol Clin. 2020 Apr 8;S1699-258X(20)30070-X [doi]
  2. Michelena X, et al. Incidence of COVID-19 in a cohort of adult and paediatric patients with rheumatic diseases treated with targeted biologic and synthetic disease-modifying anti-rheumatic drugs [texto completo]. Semin Arthritis Rheum. 2020 May 16;10.1016/j.semarthrit.2020.05.001 [doi]
  3. Páramo JA. Respuesta inflamatoria en relación con COVID-19 y otros fenotipos protrombóticos. Reumatol Clin. 2020 Jun 17;S1699-258X(20)30143-1 [doi

Trasplantes

  1. Prieto M, et al. A case of COVID-19 immediately after liver transplantation: Not only bad news. Ann Hepatobiliary Pancreat Surg. 2020 Aug 31;24(3):314-318 [doi
  2. Vicent MG, et al. COVID-19 in pediatric hematopoietic stem cell transplantation: The experience of Spanish Group of Transplant (GETMON/GETH). Pediatr Blood Cancer. 10.1002/pbc.28514. Epub 2020 Jun 23. PMID: 32573924; PMCID: PMC7361 [doi]
  3. Fernández Ruiz M, et al. COVID-19 in solid organ transplant recipients: a single-center case series from Spain. Am J Transplant. 2020 Apr 16 [doi]
  4. García-Cosío MD, et al. Heart transplantation during the COVID-19 pandemic: follow-up organization and characteristics of infected patients. Rev Esp Cardiol (Engl Ed). 2020 Dec;73(12):1077-1080 [doi
  5. Montagud-Marrahi E, et al. Preliminary data on outcomes of SARS-CoV-2 infection in a Spanish single centre cohort of kidney recipients. Am J Transplant. 2020 May 5;10.1111/ajt.15970 [doi]
  6. Rodríguez-Gandía MA, et al. Successful urgent liver transplant due to fulminant autoimmune hepatitis during the height of the COVID-19 pandemic in Spain. Gastroenterol Hepatol. 2020 Nov;43(9):537-538 [doi

Traumatología

  1. Rodríguez-Cola M, et al. Clinical features of coronavirus disease 2019 (COVID-19) in a cohort of patients with disability due to spinal cord injury [texto completo]. Spinal Cord Ser Cases. 2020 May 13;6(1):39 [doi]
  2. Muñoz Vives JM, et al. Mortality Rates of Patients with Proximal Femoral Fracture in a Worldwide Pandemic: Preliminary Results of the Spanish HIP-COVID Observational Study [texto completo]. J Bone Joint Surg Am. 2020 May 6;10.2106/JBJS.20.00686 [doi]

Urgencias

  1. Miró Ò, et al. Frequency, Risk Factors, Clinical Characteristics, and Outcomes of Spontaneous Pneumothorax in Patients With Coronavirus Disease 2019: A Case-Control, Emergency Medicine-Based Multicenter Study. Chest. 2021 Mar;159(3):1241-1255 [doi

Veterinaria

  1. Ruiz-Arrondo I, et al. Detection of SARS-CoV-2 in pets living with COVID-19 owners diagnosed during the COVID-19 lockdown in Spain: A case of an asymptomatic cat with SARS-CoV-2 in Europe. Transbound Emerg Dis. 2021 Mar;68(2):973-976 [doi]